Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and ProvidersBusiness Wire • 11/19/24
Wall Street Analysts Predict an 89.61% Upside in Pulmonx (LUNG): Here's What You Should KnowZacks Investment Research • 11/05/24
Pulmonx Corporation (LUNG) Reports Q3 Loss, Misses Revenue EstimatesZacks Investment Research • 10/30/24
Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024GlobeNewsWire • 09/09/24
Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth ConferenceGlobeNewsWire • 08/29/24
Pulmonx Corporation (LUNG) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 07/31/24
How Much Upside is Left in Pulmonx (LUNG)? Wall Street Analysts Think 80.3%Zacks Investment Research • 05/22/24
Wall Street Analysts See a 56.11% Upside in Pulmonx (LUNG): Can the Stock Really Move This High?Zacks Investment Research • 05/06/24
Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal TrialBusiness Wire • 02/26/24